Summary

NetName
67-132-78-0-24
OrgName
Ranbaxy Pharmaceuticals, Inc.
CIDR
RIR

ARIN

Country

Status

Reassigned

RegDate

2021-04-16

Updated

2021-04-16

Routing

AS Desc Country IPv4 NUMs IPv6 NUMs
AS3356 LEVEL3 - Level 3 Parent, LLC, US United States 30034416 77329203200

Whois

NetRange:       67.128.0.0 - 67.135.255.255
CIDR:           67.128.0.0/13
NetName:        CENTURYLINK-LEGACY-QWEST-INET-11
NetHandle:      NET-67-128-0-0-1
Parent:         NET67 (NET-67-0-0-0-0)
NetType:        Direct Allocation
OriginAS:
Organization:   CenturyLink Communications, LLC (CCL-534)
RegDate:        2002-07-12
Updated:        2018-02-21
Ref:            https://rdap.arin.net/registry/ip/67.128.0.0

OrgName:        CenturyLink Communications, LLC
OrgId:          CCL-534
Address:        100 CENTURYLINK DR
City:           Monroe
StateProv:      LA
PostalCode:     71201
Country:        US
RegDate:        2018-07-12
Updated:        2023-04-07
Comment:        USAGE OF IP SPACE MUST COMPLY WITH OUR ACCEPTABLE USE POLICY:
Comment:        https://www.lumen.com/en-us/about/legal/acceptable-use-policy.html
Comment:
Comment:        ADDRESSES COVERED BY THIS ORG-ID ARE NON-PORTABLE ANY ISP ANNOUNCING OR TRANSITING PORTIONS WITHIN OUR RANGES SHOULD NOT RELY ON PRESENTED LOA'S OR OLD WHOIS UNLESS THOSE RANGES ARE ALSO ACTIVELY DIRECTLY ANNOUNCED TO A LUMEN ASN. WITH ALL LOA'S THESE CONDITIONS APPLY:
Comment:
Comment:        1. You are permitted to route the Lumen IP prefixes listed via Public BGP to your alternate ISP from your ASN. Any other ASN originating the prefix listed is forbidden.
Comment:        2. The Lumen IP prefixes listed can be routed via Public BGP to your alternate ISP as long as you remain an active customer with Lumen and continue to route the prefixes over at least one Lumen Internet circuit without significant traffic engineering.
Comment:        3. Should your Internet services with Lumen be discontinued, Lumen reserves the right to have your alternate ISP terminate the routing of the Lumen IP prefixes without advanced notification, should you fail to do so.
Comment:        4. All IP Addresses assigned or allocated by Lumen to an end-user (customer or ISP) shall be considered non-portable and will be reclaimed by Lumen upon service termination.
Comment:        5. Lumen reserves the right to conduct audits to ensure the LOA conditions are being met.
Comment:
Comment:        Our looking glass is located at: https://lookingglass.centurylink.com/
Comment:
Comment:        For subpoena or court order please fax 844.254.5800 or refer to our Trust & Safety page:
Comment:        https://www.lumen.com/en-us/about/legal/trust-center/trust-and-safety.html
Comment:
Comment:        For abuse issues, please email [email protected]
Comment:        All abuse reports MUST include:
Comment:        * src IP
Comment:        * dest IP (your IP)
Comment:        * dest port
Comment:        * Accurate date/timestamp and timezone of activity
Comment:        * Intensity/frequency (short log extracts)
Comment:        * Your contact details (phone and email)
Comment:        Without these we will be unable to identify the correct owner of the IP address at that point in time.
Ref:            https://rdap.arin.net/registry/entity/CCL-534

OrgAbuseHandle: CAD54-ARIN
OrgAbuseName:   Centurylink Abuse Desk
OrgAbusePhone:  +1-877-886-6515
OrgAbuseEmail:  [email protected]
OrgAbuseRef:    https://rdap.arin.net/registry/entity/CAD54-ARIN

OrgTechHandle: QIA-ARIN
OrgTechName:   Centurylink IP Admin
OrgTechPhone:  +1-877-886-6515
OrgTechEmail:  [email protected]
OrgTechRef:    https://rdap.arin.net/registry/entity/QIA-ARIN


NetRange:       67.132.78.0 - 67.132.78.255
CIDR:           67.132.78.0/24
NetName:        67-132-78-0-24
NetHandle:      NET-67-132-78-0-1
Parent:         CENTURYLINK-LEGACY-QWEST-INET-11 (NET-67-128-0-0-1)
NetType:        Reassigned
OriginAS:       AS32754
Organization:   Ranbaxy Pharmaceuticals, Inc. (RANBA-1)
RegDate:        2021-04-16
Updated:        2021-04-16
Ref:            https://rdap.arin.net/registry/ip/67.132.78.0

OrgName:        Ranbaxy Pharmaceuticals, Inc.
OrgId:          RANBA-1
Address:        600 College Road East
Address:        Suite 2100
City:           Princeton
StateProv:      NJ
PostalCode:     08540
Country:        US
RegDate:        2004-06-01
Updated:        2021-04-16
Ref:            https://rdap.arin.net/registry/entity/RANBA-1

OrgTechHandle: JWI59-ARIN
OrgTechName:   Williams, Jack
OrgTechPhone:  +1-609-495-2770
OrgTechEmail:  [email protected]
OrgTechRef:    https://rdap.arin.net/registry/entity/JWI59-ARIN

OrgAbuseHandle: DST71-ARIN
OrgAbuseName:   Stiles, Don-marc
OrgAbusePhone:  +1-609-720-5331
OrgAbuseEmail:  [email protected]
OrgAbuseRef:    https://rdap.arin.net/registry/entity/DST71-ARIN

OrgAbuseHandle: ALATH1-ARIN
OrgAbuseName:   Alathurai, Surendran
OrgAbusePhone:  +1-609-495-2770
OrgAbuseEmail:  [email protected]
OrgAbuseRef:    https://rdap.arin.net/registry/entity/ALATH1-ARIN

OrgDNSHandle: ALATH1-ARIN
OrgDNSName:   Alathurai, Surendran
OrgDNSPhone:  +1-609-495-2770
OrgDNSEmail:  [email protected]
OrgDNSRef:    https://rdap.arin.net/registry/entity/ALATH1-ARIN

OrgNOCHandle: ALATH1-ARIN
OrgNOCName:   Alathurai, Surendran
OrgNOCPhone:  +1-609-495-2770
OrgNOCEmail:  [email protected]
OrgNOCRef:    https://rdap.arin.net/registry/entity/ALATH1-ARIN

OrgTechHandle: DST71-ARIN
OrgTechName:   Stiles, Don-marc
OrgTechPhone:  +1-609-720-5331
OrgTechEmail:  [email protected]
OrgTechRef:    https://rdap.arin.net/registry/entity/DST71-ARIN

OrgTechHandle: ALATH1-ARIN
OrgTechName:   Alathurai, Surendran
OrgTechPhone:  +1-609-495-2770
OrgTechEmail:  [email protected]
OrgTechRef:    https://rdap.arin.net/registry/entity/ALATH1-ARIN

OrgAbuseHandle: JWI59-ARIN
OrgAbuseName:   Williams, Jack
OrgAbusePhone:  +1-609-495-2770
OrgAbuseEmail:  [email protected]
OrgAbuseRef:    https://rdap.arin.net/registry/entity/JWI59-ARIN

OrgRoutingHandle: ALATH1-ARIN
OrgRoutingName:   Alathurai, Surendran
OrgRoutingPhone:  +1-609-495-2770
OrgRoutingEmail:  [email protected]
OrgRoutingRef:    https://rdap.arin.net/registry/entity/ALATH1-ARIN